GlassScriptPhysician profile
Victoria Marcel
NPI 1497365209
$2,543.20
in general payments reported to CMS, 2019-2025
18 companies · $396 in 2025
The $396 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $379 · 2022: $278 · 2023: $1,163 · 2024: $328 · 2025: $396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,177 · Travel and Lodging: $710.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,176.54 |
| Travel and Lodging | $710.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $805.26 | 2021-2023 | G7, Mymobility Platform |
| Smith+Nephew, INC. | $429.67 | 2022-2025 | Softsilk, Clancy, Bone Anchors With Arthroscopic Delivery System |
| Medical Device Business Services, INC. | $247.61 | 2021-2023 | Stratafix |
| Inari Medical, INC. | $188.16 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Heron Therapeutics, INC. | $129.89 | 2024-2025 | Zynrelef |
| Stryker Corporation | $129.41 | 2024-2025 | Mako, Axsos, Trident |
| Medtronic, INC. | $128.72 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $116.63 | 2022 | |
| Ferring Pharmaceuticals INC. | $83.42 | 2022-2023 | Euflexxa |
| Pacira Pharmaceuticals Incorporated | $68.08 | 2021-2024 | Exparel, Zilretta, Iovera |
| Bioventus LLC | $61.13 | 2021-2025 | Xcell, Durolane |
| Sanofi-Aventis U.S. LLC | $51.72 | 2021-2023 | |
| Boston Scientific Corporation | $28.24 | 2025 | Wavewriter Alpha Prime 16 |
| Ethicon US, LLC | $19.72 | 2021 | |
| Fidia Pharma USA INC. | $15.93 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $14.51 | 2025 | |
| Abbvie INC. | $12.71 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victoria Marcel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.